|
⚲
|
| Daniel Saks | |
|---|---|
| Firm | |
| Address | c/o Kellbenx, Inc, 3500 Sunrise Highway Building 200, Suite 111 Great River, NY 11739 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Kellbenx Inc | 021-485363 | Director | of 2.5 M |
||
| Kellbenx Inc | 021-380137 | Director | of 1.2 M |
||
| China Horizon Investments Group | 021-258569 | Director | 0.3 M of 5.0 M |
||
| Kellbenx Inc | 021-252546 | Director | 2.5 M of 3.8 M |
||
| Kellbenx Inc | 021-239633 | Director | of 3.1 M |
||
| Appdirect Inc | 021-215417 | Executive Officer | 35.0 M of 35.0 M |
||
| Genesis Opportunity Fund LP - Series B | 021-209514 | Executive Officer | 2.0 M | ||
| China Horizon Investments Group | 021-182202 | Director | 19.3 M of 25.0 M |
||
| Appdirect Inc | 021-181578 | Executive Officer | 11.8 M of 11.8 M |
||
| Origo Networks Corp | 021-156255 | Executive Officer | 2.7 M of 2.8 M |
||
| Pharmaco-Kinesis Corp | 021-104312 | Executive Officer | 1.2 M of 5.0 M |
||
| Neonc Technologies Inc | 021-137011 | Executive Officer | 0.1 M of 0.1 M |
||
| Genesis Capital Advisors LLC | |||||
| GCP VIII LLC | 021-204095 | Executive Officer | 1.7 M | 1.3 | |
| G-Ten Partners LLC | 021-204096 | Executive Officer | 32.1 M | 54.0 | |
| GCP IV LLC | 021-175933 | Executive Officer | 4.0 M | 4.0 | |
| GCP VII LLC | 021-175948 | Executive Officer | 1.8 M | 1.8 | |
| GCP VI LLC | 021-175930 | Executive Officer | 2.0 M | 2.0 | |
| Genesis Asset Opportunity Fund LP | 021-134427 | Executive Officer | 12.2 M | 6.0 | |
| Genesis Life Sciences Fund LP | 021-175941 | Executive Officer | 14.3 M | 12.6 | |
| Genesis Opportunity Fund LP | 021-175943 | Executive Officer | 33.0 M | 51.5 | |
| Terra RICA Fund LP | 021-175938 | Executive Officer | 4.5 M | 7.8 | |